Prudential Financial’s Artiva Biotherapeutics ARTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$694K Buy
+97,505
New +$984K ﹤0.01% 1821

Other funds holding ARTV

Prudential Financial's ARTV Position: Q3 2026 in Review

Prudential Financial opened a new position in Artiva Biotherapeutics (ARTV) in Q3 2026: 97,505 shares worth $694K. The stake represents ﹤0.01% of the portfolio and ranks #1821 among its holdings.

96 funds tracked by Wall St. Rank hold ARTV as of Q3 2026.

  • Prudential Financial held 97,505 shares of Artiva Biotherapeutics worth $694K as of Q3 2026.
  • Artiva Biotherapeutics was a new Prudential Financial position in Q3 2026.
  • Artiva Biotherapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q3 2026, its #1821 holding.
  • 96 funds tracked by Wall St. Rank held Artiva Biotherapeutics as of Q3 2026.

Based on Prudential Financial's 13F filing for Q3 2026, filed 16 Nov 2026.